Verified ComparisonLast updated: 9 April 2026
BPC-157 vs KPV
BPC-157 is a 15-amino-acid recovery peptide; KPV is a 3-amino-acid immune-modulating tripeptide. They represent different scales of peptide research.
BPC-157
Recovery
4.5/ 5
A
KPV
Immune
3.6/ 5
B
Editor's note
BPC-157 leads on tissue-repair evidence; KPV is a minimal, immune-focused tripeptide.
| Criterion | BPC-157 | KPV |
|---|---|---|
| Peptide size | 15 amino acids | 3 amino acids (tripeptide) |
| Mechanism | Tissue repair, angiogenesis | Immune modulation (α-MSH fragment) |
| Research focus | Musculoskeletal, GI | Immune, barrier function |
| Preclinical evidence | Extensive | Growing |
| Clinical trial data | Limited | Limited |
Frequently asked questions
BPC-157 has a deeper preclinical evidence base; KPV research is growing.
Want to read the full reviews?